The global genetic testing services market was valued at USD 15.0 billion in 2022 and is projected to exceed USD 31.5 billion by the end of 2031, growing at a CAGR of 8.4% from 2023 to 2031. The market is driven by increasing demand for personalized medicine, rising awareness of early disease detection, and advancements in genomic technologies across healthcare and research sectors.
Increase in prevalence of genetic disorders and rise in awareness about personalized medicine is driving the genetic testing services market size. Advancements in technology, such as next-generation sequencing and gene editing techniques, have improved the accuracy, efficiency, and affordability of genetic testing, further fueling market expansion.
Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10235
Increase in adoption of direct-to-consumer gene testing kits has made genetic testing more accessible to individuals. These kits allow consumers to obtain genetic information from the comfort of their homes, enabling personalized health management and ancestry exploration, thereby boosting the genetic testing services industry.
Key Findings of the Market Report
- Diagnostic Testing and Carrier Screening are the largest segments, with carrier testing accounting for 27.5% of the market in 2026.
- Oncology is the fastest-growing application, with a projected 17.1% CAGR, as liquid biopsies become a primary tool for cancer monitoring.
- Next-Generation Sequencing (NGS) captured 46.13% of technology revenue in 2025 and remains the gold standard for comprehensive genomic profiling in 2026.
- Hospitals & Clinics remain the primary end-users, holding a 42.41% share, though specialized diagnostic laboratories are seeing rapid expansion.
Global Market: Growth Drivers
- Prevalence of Rare and Chronic Diseases: With 72–80% of rare diseases linked to genetic mutations, early testing is increasingly mandated by global health bodies.
- Personalized Medicine (Pharmacogenomics): Increasing use of genetic data to tailor drug dosages and avoid adverse reactions (ADRs).
- AI and Cloud Integration: Shift from high-CAPEX local servers to cloud-based AI interpretation platforms billed as recurring subscriptions.
- Mainstream Insurance Coverage: Expanding reimbursement policies in developed markets for prenatal screening and hereditary cancer panels.
Global Market: Key Players
The competitive landscape is characterized by a mix of specialized genomic pioneers and massive diagnostic conglomerates.
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Inc.
- Laboratory Corp of America Holdings (LabCorp)
- F. Hoffmann-La Roche Ltd
- Eurofins Scientific SE
- Exact Sciences Corp
- Myriad Genetics, Inc.
- 23andMe Holding Co. (DTC Leader)
- GeneDx
- NeoGenomics Laboratories
Global Market: Segmentation
By Test Type
- Carrier Testing (2026 Leader)
- Diagnostic Testing
- Prenatal & Newborn Screening
- Predictive & Presymptomatic Testing
- Pharmacogenomic Testing
By Technology
- Next-Generation Sequencing (NGS) (Dominant)
- Polymerase Chain Reaction (PCR)
- DNA Microarray
- Cytogenetic Testing (FISH)
By Application
- Oncology (High Growth)
- Genetic Disease Diagnosis
- Reproductive Health
- Ancestry & DTC Wellness
By End-User
- Hospitals & Clinics
- Diagnostic Laboratories
- Research & Academic Institutes
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=10235<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com